1. Najafi, M., Shayesteh, M. R. H., Mortezaee, K., Farhood, B., & Haghi-Aminjan, H. (2020). The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review. Life Sciences, 241, 117173.
2. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249.
3. Young, R. C., Ozols, R. F., & Myers, C. E. (1981). The anthracycline antineoplastic drugs. New England Journal of Medicine, 305, 139–153.
4. Narkiewicz, K., Ratcliffe, L. E., Hart, E. C., Briant, L. J., Chrostowska, M., Wolf, J., Szyndler, A., Hering, D., Abdala, A. P., & Manghat, N. (2016). Unilateral carotid body resection in resistant hypertension: A safety and feasibility trial. JACC: Basic to Translational Science, 1, 313–324.
5. Hardaway, B. W. (2019). Adriamycin-associated cardiomyopathy: Where are we now? Updates in pathophysiology, dose recommendations, prognosis, and outcomes. Current Opinion in Cardiology, 34, 289–295.